vs

Side-by-side financial comparison of Danaher Corporation (DHR) and Ecolab (ECL). Click either name above to swap in a different company.

Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $4.1B, roughly 1.5× Ecolab). Danaher Corporation runs the higher net margin — 17.3% vs 10.6%, a 6.7% gap on every dollar of revenue. On growth, Ecolab posted the faster year-over-year revenue change (10.0% vs 3.7%). Over the past eight quarters, Danaher Corporation's revenue compounded faster (1.8% CAGR vs 1.0%).

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

Ecolab Inc., headquartered in Saint Paul, Minnesota, provides products related to water treatment, sanitation, and hygiene, primarily to commercial and industrial customers.

DHR vs ECL — Head-to-Head

Bigger by revenue
DHR
DHR
1.5× larger
DHR
$6.0B
$4.1B
ECL
Growing faster (revenue YoY)
ECL
ECL
+6.4% gap
ECL
10.0%
3.7%
DHR
Higher net margin
DHR
DHR
6.7% more per $
DHR
17.3%
10.6%
ECL
Faster 2-yr revenue CAGR
DHR
DHR
Annualised
DHR
1.8%
1.0%
ECL

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
DHR
DHR
ECL
ECL
Revenue
$6.0B
$4.1B
Net Profit
$1.0B
$432.6M
Gross Margin
60.3%
Operating Margin
22.6%
15.3%
Net Margin
17.3%
10.6%
Revenue YoY
3.7%
10.0%
Net Profit YoY
7.9%
1.3%
EPS (diluted)
$1.45
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHR
DHR
ECL
ECL
Q2 26
$4.1B
Q1 26
$6.0B
Q4 25
$6.8B
$4.2B
Q3 25
$6.1B
$4.2B
Q2 25
$5.9B
$4.0B
Q1 25
$5.7B
$3.7B
Q4 24
$6.5B
$4.0B
Q3 24
$5.8B
$4.0B
Net Profit
DHR
DHR
ECL
ECL
Q2 26
$432.6M
Q1 26
$1.0B
Q4 25
$1.2B
$563.9M
Q3 25
$908.0M
$585.0M
Q2 25
$555.0M
$524.2M
Q1 25
$954.0M
$402.5M
Q4 24
$1.1B
$472.9M
Q3 24
$818.0M
$736.5M
Gross Margin
DHR
DHR
ECL
ECL
Q2 26
Q1 26
60.3%
Q4 25
58.0%
44.0%
Q3 25
58.2%
44.8%
Q2 25
59.3%
44.8%
Q1 25
61.2%
44.2%
Q4 24
59.5%
43.3%
Q3 24
58.7%
43.4%
Operating Margin
DHR
DHR
ECL
ECL
Q2 26
15.3%
Q1 26
22.6%
Q4 25
22.0%
17.0%
Q3 25
19.1%
18.3%
Q2 25
12.8%
17.6%
Q1 25
22.2%
15.0%
Q4 24
21.8%
14.6%
Q3 24
16.5%
26.1%
Net Margin
DHR
DHR
ECL
ECL
Q2 26
10.6%
Q1 26
17.3%
Q4 25
17.5%
13.4%
Q3 25
15.0%
14.0%
Q2 25
9.3%
13.0%
Q1 25
16.6%
10.9%
Q4 24
16.6%
11.8%
Q3 24
14.1%
18.4%
EPS (diluted)
DHR
DHR
ECL
ECL
Q2 26
$1.52
Q1 26
$1.45
Q4 25
$1.69
$1.98
Q3 25
$1.27
$2.05
Q2 25
$0.77
$1.84
Q1 25
$1.32
$1.41
Q4 24
$1.50
$1.65
Q3 24
$1.12
$2.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHR
DHR
ECL
ECL
Cash + ST InvestmentsLiquidity on hand
$519.8K
Total DebtLower is stronger
$8.5M
Stockholders' EquityBook value
$10.0M
Total Assets
$25.0M
Debt / EquityLower = less leverage
0.85×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHR
DHR
ECL
ECL
Q2 26
$519.8K
Q1 26
Q4 25
$646.2M
Q3 25
$2.0B
Q2 25
$1.9B
Q1 25
$1.2B
Q4 24
$1.3B
Q3 24
$1.3B
Total Debt
DHR
DHR
ECL
ECL
Q2 26
$8.5M
Q1 26
Q4 25
$18.4B
$7.4B
Q3 25
$16.9B
$8.1B
Q2 25
$17.4B
$7.5B
Q1 25
$16.5B
$7.0B
Q4 24
$16.0B
$6.9B
Q3 24
$17.5B
$7.0B
Stockholders' Equity
DHR
DHR
ECL
ECL
Q2 26
$10.0M
Q1 26
Q4 25
$52.5B
$9.8B
Q3 25
$51.1B
$9.7B
Q2 25
$52.3B
$9.3B
Q1 25
$50.8B
$8.9B
Q4 24
$49.5B
$8.8B
Q3 24
$51.3B
$8.5B
Total Assets
DHR
DHR
ECL
ECL
Q2 26
$25.0M
Q1 26
Q4 25
$83.5B
$24.7B
Q3 25
$79.9B
$23.9B
Q2 25
$81.6B
$23.7B
Q1 25
$79.1B
$22.4B
Q4 24
$77.5B
$22.4B
Q3 24
$80.6B
$22.1B
Debt / Equity
DHR
DHR
ECL
ECL
Q2 26
0.85×
Q1 26
Q4 25
0.35×
0.75×
Q3 25
0.33×
0.83×
Q2 25
0.33×
0.81×
Q1 25
0.32×
0.79×
Q4 24
0.32×
0.79×
Q3 24
0.34×
0.82×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHR
DHR
ECL
ECL
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$1.1B
FCF MarginFCF / Revenue
18.2%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$5.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHR
DHR
ECL
ECL
Q2 26
Q1 26
$1.3B
Q4 25
$2.1B
$1.1B
Q3 25
$1.7B
$791.3M
Q2 25
$1.3B
$701.8M
Q1 25
$1.3B
$369.4M
Q4 24
$2.0B
$766.7M
Q3 24
$1.5B
$786.7M
Free Cash Flow
DHR
DHR
ECL
ECL
Q2 26
Q1 26
$1.1B
Q4 25
$1.7B
$758.0M
Q3 25
$1.4B
$529.7M
Q2 25
$1.1B
$485.1M
Q1 25
$1.1B
$131.5M
Q4 24
$1.5B
$407.0M
Q3 24
$1.2B
$550.3M
FCF Margin
DHR
DHR
ECL
ECL
Q2 26
Q1 26
18.2%
Q4 25
25.5%
18.1%
Q3 25
22.6%
12.7%
Q2 25
18.4%
12.1%
Q1 25
18.4%
3.6%
Q4 24
23.0%
10.2%
Q3 24
21.0%
13.8%
Capex Intensity
DHR
DHR
ECL
ECL
Q2 26
Q1 26
4.0%
Q4 25
5.4%
7.9%
Q3 25
4.8%
6.3%
Q2 25
4.2%
5.4%
Q1 25
4.3%
6.4%
Q4 24
7.9%
9.0%
Q3 24
5.1%
5.9%
Cash Conversion
DHR
DHR
ECL
ECL
Q2 26
Q1 26
1.28×
Q4 25
1.77×
1.93×
Q3 25
1.83×
1.35×
Q2 25
2.41×
1.34×
Q1 25
1.36×
0.92×
Q4 24
1.86×
1.62×
Q3 24
1.85×
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHR
DHR

Segment breakdown not available.

ECL
ECL

Product and equipment sales$3.2B78%
Service and lease sales$891.5M22%

Related Comparisons